Advertisements

Ortofen LMP

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Ortofen LMP

Property Description
Active ingredient Diclofenac
Forms Tablets, injection solution, gel, ointment
Pharmacological class Nonsteroidal Anti-Inflammatory Drug (NSAID)
Common use Pain and inflammation management
Origin Synthetic compound

Ortofen LMP is a distinct pharmaceutical preparation whose active ingredient is the potent anti-inflammatory agent, Diclofenac, a compound clinically recognized for its reliable efficacy in managing pain and inflammation.

As a synthetic agent, Ortofen LMP is structurally classified as a phenylacetic acid derivative, placing it firmly within the larger class of medications known as Nonsteroidal Anti-Inflammatory Drugs (NSAIDs). The formulation is a monocomponent product, relying solely on the established strength of Diclofenac, making it a critical tool used in medical practice for systemic or local relief.

What Type of Medicine is Ortofen LMP?

Ortofen LMP is defined as a potent Nonsteroidal Anti-Inflammatory Drug (NSAID) and functions chemically as a highly effective Cyclooxygenase (COX) inhibitor. Diclofenac possesses robust anti-inflammatory properties, providing significant symptomatic relief across a range of painful conditions.

This classification means the medication’s primary action is to interrupt the biological processes that produce prostaglandins, which are fatty acid compounds responsible for initiating and sustaining the inflammatory response in the body. By inhibiting their synthesis, Ortofen LMP achieves a fundamental therapeutic benefit: it provides an analgesic effect to mitigate the sensation of pain, an anti-inflammatory effect to reduce swelling and irritation, and a secondary antipyretic effect to help normalize fever, confirming its utility in managing underlying inflammatory states.

Available Forms of Ortofen LMP

Ortofen LMP is manufactured in a range of different pharmaceutical preparations to ensure optimal delivery of the active substance, Diclofenac.

These preparations include common formulations for systemic delivery, such as tablets for oral intake and solution for injection for parenteral administration, as well as forms for localized treatment, specifically gel and ointment for topical/cutaneous application. This comprehensive availability across multiple dosage forms means that the anti-inflammatory and analgesic effects of Diclofenac can be delivered appropriately by a medical professional, whether achieving widespread relief throughout the body or maximizing concentration at a specific site of discomfort, such as an inflamed joint or soft tissue, a versatility highly valued in standard therapeutic practice.

Regulatory References

  1. Diclofenac: MedlinePlus Drug Information
Advertisements

What side effects are possible with Ortofen LMP?

Possible Side Effects and Safety Information

The safety profile of Ortofen LMP is based on regulatory documentation that classifies potential effects by their frequency (Very Common, Common, Uncommon, Rare, Very Rare) and the affected body system (System Organ Class).

Serious Adverse Reactions and Systemic Risks

Official safety information highlights the risk of serious, potentially fatal events affecting major body systems:

  • Cardiovascular and Thrombotic Events: The risk of serious cardiovascular thrombotic events, such as myocardial infarction (heart attack) and stroke, may increase with higher doses and longer treatment duration. The medicine is generally contraindicated in patients with established congestive heart failure (NYHA Class II-IV), ischaemic heart disease, or cerebrovascular disease.
  • Gastrointestinal (GI) Toxicity: Serious GI bleeding, ulceration, and perforation are documented risks that may be fatal. These risks are also linked to the dose and duration of use. A history of GI bleeding or perforation related to previous similar therapy is a contraindication.
  • Hepatic and Renal Events: The risk of acute renal failure or hepatic failure is recognized. Patients with severe existing renal or hepatic failure should not use this medicine.
  • Hypersensitivity and Skin Reactions: Serious skin reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis, as well as anaphylactic or anaphylactoid reactions, are documented as rare but serious risks.

Safety Restrictions and Limitations

Regulatory documents mandate specific limitations on use:

Restriction Category Key Requirement/Limitation
Dose/Duration Pattern Use the lowest effective dose for the shortest possible duration.
Pregnancy Contraindicated during the third trimester of pregnancy.
High-Risk Populations Use requires particular caution and monitoring in elderly patients and those with uncontrolled hypertension or existing fluid retention.

All officially documented adverse reactions are categorized within this frequency and system-organ-class framework to structure the medicine’s comprehensive safety profile.

Advertisements

Overdose and Emergency Response

The official regulatory documentation for Diclofenac (the active ingredient in Ortofen LMP) details specific manifestations and required actions in the event of overexposure.

A suspected overdose may initially present with gastrointestinal symptoms, including nausea, vomiting, diarrhoea, and pain in the upper abdomen. Central Nervous System (CNS) effects may also be observed, such as headache, dizziness, drowsiness, agitation, and tinnitus. In cases of significant poisoning, more severe CNS effects like convulsions, loss of consciousness, or coma have been documented.

Overdose carries a documented risk of serious toxicity to vital organs. Life-threatening outcomes cited in regulatory warnings include acute renal failure, liver damage leading to acute hepatic failure, hypotension, and respiratory depression. Patients with existing renal or hepatic impairment may face an increased risk of severe toxicity.

Regulatory authorities mandate that you seek immediate medical attention or contact emergency services immediately following the ingestion of a potentially toxic dose. This urgent action is necessary because no specific antidote is known for Diclofenac overdosage. Management is strictly symptomatic and supportive treatment and requires close medical observation; initial procedures may involve gastric decontamination, such as the administration of activated charcoal.

Advertisements

Therapeutic Uses of Ortofen LMP

Ortofen LMP, which contains Diclofenac, is commonly used to provide symptomatic relief by addressing symptoms that become more disruptive during flare-ups. The medication may be part of symptomatic management for conditions characterized by periods of heightened symptoms, such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. Its primary therapeutic benefit is relevant for easing symptoms related to physical discomfort.


Managing Symptom Clusters

This medication is relevant when supportive symptom management is appropriate for conditions presenting with systemic or localized discomfort. It is used to help manage the daily symptoms of joint pain, stiffness, and swelling, contributing to easing the overall symptom load and may assist with maintaining a sense of stability during symptomatic periods. The medication is applied in addressing symptoms associated with acute or episodic changes, including pain and swelling from acute musculoskeletal disorders, or recurrent manifestations like gouty arthritis flare-ups, acute migraine attacks, and intense menstrual cramps. It is relevant for easing symptoms that interfere with daily comfort.

“The medication is used in situations involving certain distressing symptoms related to physical discomfort and inflammatory states.”

Quick Fact: Symptomatic Support for Joint Pain, Stiffness, and Swelling

Advertisements

Eligibility and Restrictions for Use

Who can and cannot use Ortofen LMP?

The population eligibility for Ortofen LMP (Diclofenac) is strictly governed by authoritative regulatory documentation. Use is typically allowed for adults but is defined by several contraindications and restrictions based on the patient's existing health conditions.


Absolute Prohibitions (Contraindications)

Official labeling mandates that Ortofen LMP must not be used in patients with:

  • Known hypersensitivity to diclofenac, aspirin, or any other Nonsteroidal Anti-Inflammatory Drug (NSAID).
  • An active stomach or intestinal ulcer, bleeding, or perforation.
  • Established severe cardiovascular disease, including severe congestive heart failure (NYHA Class II-IV), ischaemic heart disease, or cerebrovascular disease.
  • The third trimester of pregnancy (from 30 weeks gestation onward).
  • Perioperative pain in the setting of Coronary Artery Bypass Graft (CABG) surgery.

Restricted and Conditional Use

Use is restricted or requires special consideration in specific patient populations:

Population Category Regulatory Status (Requirement)
Age Limitations Not established or not recommended for many systemic forms in the pediatric population (under 18). Older adults require caution due to increased risk of serious adverse events.
Organ Impairment Contraindicated in severe renal or hepatic failure. Use is generally avoided in advanced renal disease and requires caution and monitoring in impaired hepatic function.
GI History Patients with a prior history of gastrointestinal bleeding or ulceration must use the medicine with extreme caution.
Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile of Ortofen LMP, which contains Diclofenac, is formally documented by regulatory authorities and focuses on pharmacokinetic and pharmacodynamic interactions.

Pharmacokinetic and Metabolic Interactions

Co-administration with strong CYP inhibitors (e.g., Voriconazole) significantly increases Diclofenac's maximum plasma concentration ( C max) and total exposure ( AUC) by reducing its metabolic clearance. Diclofenac can also reduce the renal clearance of specific co-administered drugs, leading to an increase in their plasma concentrations. This effect is documented for medicines such as Lithium and Methotrexate, which may enhance their potential toxicity.

Pharmacodynamic and Risk Reinforcement

Certain combinations result in additive risk reinforcement as described in regulatory documents:

  • Other Systemic NSAIDs: Co-administration is not recommended due to an additive risk of serious gastrointestinal (GI) adverse events.
  • ACE Inhibitors / ARBs: Concurrent use can diminish the antihypertensive effect and carries an increased risk of acute renal function deterioration. This risk is noted to be heightened in the elderly and in patients who are volume-depleted.
  • Anticoagulants, Anti-platelet Agents, and SSRIs: Combining Diclofenac with these classes increases the risk of serious bleeding or GI bleeding.
  • Alcohol: Consumption of alcohol is documented to increase the risk of serious gastrointestinal bleeding associated with NSAID use.

Contraindicated and Restricted Use

Diclofenac is formally contraindicated in the peri-operative setting of Coronary Artery Bypass Graft (CABG) surgery. Additionally, in some regions, high-dose systemic Diclofenac is contraindicated in patients with established cardiovascular diseases.

Advertisements

Mechanism of Action

How Ortofen LMP Works

Ortofen LMP, which contains the active substance diclofenac, acts by modulating core chemical pathways involved in eicosanoid synthesis. Its action is characterized by a sequential mechanism that moves from a molecular block to a resulting physiological consequence.


Molecular Block: Inhibition of COX Enzymes

This mechanism begins at the molecular level with the non-selective inhibition of the Cyclooxygenase (COX-1 and COX-2) enzymes. Diclofenac physically blocks the active site of these enzymes, preventing them from metabolizing their substrate, arachidonic acid. This initial action is significant, as the COX enzymes are the primary biological targets responsible for initiating the pathway.


⬇️ Pathway Effect: Reduction of Prostaglandin Synthesis

The consequence of blocking the COX enzymes is a reduction in the synthesis and local concentration of prostaglandins—potent, local chemical messengers. This reduction represents a key pathway effect because prostaglandins are signaling molecules that chemically sensitize peripheral nerve endings and influence local vascular and cellular permeability.


️ Physiological Consequence: Dampened Signaling

By lowering the local concentration of these signaling mediators, the drug's mechanism lowers the chemical sensitization of nerve endings and reduces the level of chemical signaling. This adjustment is the basis of the drug's overall physiological effect profile.

Advertisements

Dosage and Administration Information

Ortofen LMP, which contains the active substance diclofenac, is a non-steroidal anti-inflammatory drug (NSAID) used to relieve pain and inflammation. This medication must be used exactly as prescribed by your healthcare provider.

General Administration Guidelines

  • Dosage: Your doctor will determine the appropriate dose and frequency based on your medical condition. For most inflammatory conditions, oral diclofenac doses generally range from 100 mg to 200 mg per day in divided doses, though the specific dose depends on the formulation (e.g., delayed-release, extended-release, or immediate-release) and the condition being treated.
  • Lowest Effective Dose: To minimize potential cardiovascular and gastrointestinal risks, use the lowest effective dose for the shortest duration necessary to control symptoms.
  • Administration: Swallow tablets or capsules whole with a drink of water or milk. Do not crush, break, or chew them, as this can affect the way the medication is released into your body.
  • With Food: If you experience stomach upset, it is generally recommended to take the tablets with food or milk to reduce irritation, although some specific formulations must be taken on an empty stomach. Always follow the specific instructions on your prescription label.
  • Missed Dose: If you miss a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and resume your regular schedule. Do not double your dose to make up for a missed one.

Important Precautions

Contact your doctor immediately if symptoms worsen or if you develop new, concerning symptoms while taking this medication. Do not use this medication for longer than prescribed. Individuals who are 65 years or older or have a history of peptic ulcers or gastrointestinal bleeding are at a higher risk for serious gastrointestinal events and should be monitored closely.

Advertisements

Recent Clinical Evidence

Evidence of Therapeutic Approach

Research has explored the activity of this combination treatment in relation to measures of inflammation. Studies examined whether this activity was associated with changes in reports of pain and swelling associated with chronic conditions.

This therapeutic approach was explored to see if a combination of two mechanisms of action, [Mechanism A] and [Mechanism B], was associated with observed differences in treatment effect, and included an assessment of the frequency of adverse events, compared to a single agent with a different mechanism.


Key Clinical Trial Findings

Key Phase III trials measured changes in the quality of life for participants and tracked the incidence and severity of symptoms reported, primarily focusing on musculoskeletal conditions.

Outcome Measure Finding (6 Months) Time Frame Observed
Disease Activity (e.g., DAS28) Reported average change of -Y (95% CI: [-Z, -W]) from baseline. 6 months
Functional Status (e.g., HAQ) Average change in score of -A points (95% CI: [-B, -C]) from baseline. 12 months

Long-term follow-up studies reported a change in disease activity over periods up to 5 years, with some studies including a comparison to single-agent therapies. Researchers continue to evaluate the long-term profile in a broader population.


Safety and Tolerability Profile

Reported side effects typically included nausea, headache, and injection site reactions, and the studies observed the frequency and severity of these events. Studies tracked the rate of discontinuation due to adverse events, which was X% in the treatment group, compared to Y% in the placebo group.

Studies documented unusual fatigue as a possible adverse event. Trial exclusion criteria typically included a history of liver issues; the study protocols indicated that patients with a history of liver issues were generally not eligible for inclusion.

Key Studies & References Clinical Practice Guideline for the Management of Chronic Inflammatory Joint Disease (2024 Update)

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Ortofen LMP (FAQ)


Q: Can I take Ortofen LMP with other NSAIDs or aspirin?

A: According to official regulatory information, combining Ortofen LMP with other systemic Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) or aspirin is generally not recommended. This is due to an increased risk of serious gastrointestinal adverse events, such as bleeding or ulceration, when multiple agents are used concurrently.


Q: What should I do if I experience a side effect?

A: Official information highlights the risk of serious side effects. If signs of a heart attack, stroke, or a severe allergic reaction occur, regulatory information recommends seeking emergency medical attention. For other concerning symptoms or side effects, official documents usually state that patients should contact a healthcare provider.


Q: Can I drink alcohol while I am taking Ortofen LMP?

A: Regulatory documents explicitly state that consuming alcohol while using this medication increases the risk of serious gastrointestinal bleeding. This risk is associated with the use of NSAIDs.


Q: What is the typical adult dosage for Ortofen LMP?

A: Official documents describe a typical dosage range for treating inflammatory conditions, though the specific dose is always determined by the healthcare provider. Official guidelines emphasize using the lowest effective dose for the shortest duration necessary to control symptoms.


Q: How quickly will Ortofen LMP start working after I take it?

A: Regulatory documents detailing the drug's absorption indicate there may be a delay in the onset of absorption of the oral tablet. This absorption time can vary, usually ranging from 1 to 4.5 hours, depending on factors such as whether the medication is taken with or without food.


Q: Can I use Ortofen LMP for a common headache or fever?

A: Ortofen LMP, which is Diclofenac, possesses pain-relieving (analgesic) and fever-reducing (antipyretic) properties. While some formulations are indicated for specific types of acute pain, such as migraine attacks, the drug's official indications may not list common fever, but rather specific types of pain or inflammation.


Q: Does Ortofen LMP cause weight gain or change my sleep?

A: Official documents listing potential adverse reactions have reported effects such as changes in weight, fluid retention (edema), insomnia (sleeplessness), and drowsiness. These effects have been reported in postmarketing experience and are included in the recognized safety profile.

Advertisements

How should Ortofen LMP be stored and disposed of?

How to Store and Dispose of Ortofen LMP?

The storage and disposal of Ortofen LMP (Diclofenac) must strictly follow the conditions defined in the official regulatory labeling to maintain product stability and ensure safety.


Official Storage Requirements

Detail Requirement
Temperature: Store below 25 °C.
Protection: Must be protected from moisture and light.
Packaging: Store the medicine in its original package.
Child Safety: Keep the medicine out of the sight and reach of children.

Official Disposal Instructions

Any unused medicinal product or waste material should be disposed of in accordance with local requirements. This adherence to official local guidelines is mandatory for safe and environmentally responsible handling of the expired or remaining product.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Ortofen LMP found in:

A-Z Index: